Global & Public Health (all articles)
[Abstract Only] Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome
8 Oct, 2020 | 08:59h | UTCInterferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome – New England Journal of Medicine (link to abstract – $ for full-text)
Global maps of travel time to healthcare facilities
8 Oct, 2020 | 08:54h | UTCGlobal maps of travel time to healthcare facilities – Nature Medicine
Commentary on Twitter
It's pretty striking how far and how long it takes to get to #healthcare facilities around the world
New paper @NatureMedicine https://t.co/TME4zY4yXf
by Daniel Weiss @telethonkids @CurtinUni and colleagues pic.twitter.com/aQXW2gQ57t— Eric Topol (@EricTopol) September 28, 2020
Randomized trial: Lopinavir–ritonavir not beneficial for patients admitted to hospital with COVID-19
7 Oct, 2020 | 08:50h | UTCCommentaries: Study: HIV drug of no benefit to hospitalized COVID patients – CIDRAP AND Antiviral monotherapy for hospitalised patients with COVID-19 is not enough – The Lancet AND
Commentary on Twitter
NEW—Lopinavir-ritonavir is not an effective treatment for patients hospitalised with #COVID19: finding from RECOVERY, randomised, controlled, open-label, platform trial https://t.co/RpiUAvWF1I pic.twitter.com/uI3yiQbEgK
— The Lancet (@TheLancet) October 6, 2020
WHO: COVID-19 disrupting mental health services in most countries
7 Oct, 2020 | 09:24h | UTCCOVID-19 disrupting mental health services in most countries, WHO survey – World Health Organization
Three lessons COVID-19 has taught us about Open Access publishing
7 Oct, 2020 | 09:19h | UTC
ACP Guidance: Should Remdesivir be used for the treatment of patients with COVID-19?
7 Oct, 2020 | 09:21h | UTCSystematic review: Remdesivir for Adults With COVID-19: A Living Systematic Review for an American College of Physicians Practice Points – Annals of Internal Medicine
Flurry of coronavirus reinfections leaves scientists puzzled
7 Oct, 2020 | 09:15h | UTCFlurry of coronavirus reinfections leaves scientists puzzled – The Guardian
Face masks: what the data say
7 Oct, 2020 | 09:17h | UTCFace masks: what the data say – Nature
Commentary on Twitter
#Facemasks: what the data say.#Masks work, but they are not infallible.
You decrease your risk of contagion if you wear them properly AND apply other #hygiene measures, keep your physical distance, and ventilate indoor spaces well.#covid #covid19
https://t.co/uNqehIC2pF— Vanessa Campo-Ruiz, MD PhD (@VCSTX) October 6, 2020
Covid-19: Risk of death more than doubled in people who also had flu, English data show
7 Oct, 2020 | 09:11h | UTCCovid-19: Risk of death more than doubled in people who also had flu, English data show – The BMJ
Original study (preprint): Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design – medRxiv
Commentary on Twitter
People infected with both flu and SARS-CoV-2 are more than twice as likely to die as someone with the new coronavirus alone, emerging evidence analysed by @PHE_uk has found. The data has been published as a preprint on medRxivhttps://t.co/3Qv3gxGRXB
— The BMJ (@bmj_latest) September 23, 2020
WHO: 10% of world’s people may have been infected with virus
6 Oct, 2020 | 01:00h | UTCWHO: 10% of world’s people may have been infected with virus – Associated Press
See also: One in 10 may have caught COVID, as world heads into ‘difficult period’: WHO – Reuters
Updated CDC Guidance: How COVID-19 Spreads
6 Oct, 2020 | 00:59h | UTCHow COVID-19 Spreads – Centers for Disease Control and Prevention
Commentary: CDC revises coronavirus guidance to acknowledge that it spreads through airborne transmission – CNBC
Long-term health consequences of COVID-19
6 Oct, 2020 | 00:58h | UTCLong-term Health Consequences of COVID-19 – JAMA
Commentary on Twitter
Persistent post-COVID symptoms could be the from direct tissue invasion by the virus, profound inflammation & cytokine storm, related immune system damage, hypercoagulable state, or some combination https://t.co/G8tI9U3TaL @CarlosdelRio7 lfcollins_md @PreetiNMalani
— JAMA (@JAMA_current) October 5, 2020
Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US
6 Oct, 2020 | 00:56h | UTCCommentaries: Americans over 30 have been drinking more during the coronavirus pandemic, research shows – CNN AND Adult Alcohol Use Has Increased During the COVID-19 Pandemic – NEJM Journal Watch AND Americans Have Turned To Alcohol During The Coronavirus Pandemic, And It’s Concerning – Forbes
Commentary on Twitter
Survey study shows Americans increased their frequency of alcohol consumption during #COVID19, compared with a year earlier. Women also reported increases in days of heavy drinking and in alcohol-related problems. @MichaelSPollard https://t.co/TVjmpoj9ja
— JAMA Network Open (@JAMANetworkOpen) September 30, 2020
Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19
6 Oct, 2020 | 00:52h | UTC
Commentary on Twitter
https://twitter.com/DrZoeHyde/status/1313098114958417921
Report: Adolescent with COVID-19 as the source of an outbreak at a 3-week family gathering
6 Oct, 2020 | 00:50h | UTC
A ‘herd mentality’ can’t stop the COVID-19 pandemic. Neither can a weak vaccine
6 Oct, 2020 | 00:53h | UTC
Patient page: Risk of COVID-19 during air travel
6 Oct, 2020 | 00:45h | UTCRisk of COVID-19 During Air Travel – JAMA
Commentary on Twitter
"Risk of #COVID19 During Air Travel" https://t.co/wHXgNqeJem via @JAMA_current @JAMANetworkOpen cc @DrJenGunter
"The risk of contracting coronavirus disease 2019 (COVID-19) during air travel is lower than from an office building, classroom, supermarket, or commuter train." pic.twitter.com/SZjCoHlrnw
— Timothy Caulfield (@CaulfieldTim) October 4, 2020
People with ‘silent’ COVID-19 have as much coronavirus as those with symptoms
6 Oct, 2020 | 00:48h | UTCOriginal Study: Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection – Thorax
Commentary on Twitter
People with ‘silent’ COVID-19 infection have as much coronavirus in their noses and throats as those with symptoms.https://t.co/DUQvmbBadb
Podcast: https://t.co/xyXT5jlBA9— ThoraxBMJ (@ThoraxBMJ) September 22, 2020
Video: Who gets coronavirus vaccine first?
4 Oct, 2020 | 23:33h | UTCWho Gets Coronavirus Vaccine First? – JAMA
Framework for equitable allocation of COVID-19 vaccine
4 Oct, 2020 | 23:34h | UTCRelated: WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination – World Health Organization AND An ethical framework for global vaccine allocation – Science AND US Adults’ Preferences for Public Allocation of a Vaccine for Coronavirus Disease 2019 – JAMA Network Open
Study: Four out of five people with sudden loss of smell or taste had COVID-19
4 Oct, 2020 | 23:30h | UTCCommentaries: Coronavirus: Loss of smell may be clearer sign than cough – BBC AND Coronavirus: Four out of five with sudden loss of smell or taste had COVID-19, study finds – Sky News
Commentary on Twitter
Four out of five people who experienced sudden loss of smell or taste had #COVID19, in a study by @ProfBatterhamMD and colleagues @ucl and @uclh #SARSCoV2
🔎 @PLOSMedicine paper: https://t.co/MoGTowbPus
📰 @SkyNews article: https://t.co/qgZJt9NHk6— PLOS (@PLOS) October 2, 2020
Podcast: Sweden and COVID-19
4 Oct, 2020 | 23:31h | UTC
The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology
4 Oct, 2020 | 23:26h | UTCThe use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology – Nature
Commentary on Twitter
In this Perspective, @khgrantz, @hanmered, @datcummings, @CJEMetcalf, @GilesJohnR, @shrutihmehta, @sss_cubed, @alabriqu, @nish_epi, @Caroline_OF_B, @apwez review the different applications for mobile phone data to support the COVID-19 pandemic responsehttps://t.co/tvmRlYcMww
— Nature Communications (@NatureComms) October 2, 2020
Perspective: What we know about vitamin D and Covid-19 (spoiler: not much)
4 Oct, 2020 | 23:28h | UTCWhat We Know About Vitamin D and Covid-19 – Medium
De-adopting low-value care: Evidence, eminence, and economics
4 Oct, 2020 | 23:20h | UTCDe-adopting Low-Value Care: Evidence, Eminence, and Economics – JAMA (free for a limited period)
Author Interview: De-Adopting Low-Value Care—Evidence, Eminence, and Economics
Commentary on Twitter
Evidence alone is NOT sufficient for many healthcare professionals to abandon low-value treatments that provide little or no benefit to patients.
Often it's only when their financial reimbursement is reduced or stopped that their use declines quickly. https://t.co/YiggZyqUMp
— The Sp⚽️rts Physio (@AdamMeakins) October 3, 2020